Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 13, 2013 - Issue 9
Submit an article Journal homepage
1,270
Views
54
CrossRef citations to date
0
Altmetric
Original Research

Efficacy of omalizumab in chronic spontaneous urticaria refractory to conventional therapy: analysis of 110 patients in real-life practice

Moises Labrador-HorrilloAllergy Section, Medicine Department, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Passeig Vall d'Hebron, 119-129, 08035, Barcelona, Spain+34 93 2746169; +34 93 2746169; [email protected]
, MD PhD,
Antonio ValeroPulmonary and Allergy Department, Hospital Clinic i Universitari de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
,
Manuel VelascoDermatology Department, Hospital Arnau de Vilanova, Valencia, Spain
,
Ignacio JáureguiAllergy Department, Hospital Universitario Basurto, Bilbao, Spain
,
Joaquin SastreAllergy Department, Fundación Jiménez Diaz, Madrid, Spain
,
Joan BartraPulmonary and Allergy Department, Hospital Clinic i Universitari de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
,
Juan Francisco SilvestreDermatology Department, Hospital General Universitario de Alicante, Alicante, Spain
,
Javier Ortiz de FrutosDermatology Department, Hospital 12 de Octubre, Madrid, Spain
,
Ana Gimenez-ArnauDermatology Department, Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, Spain
&
Marta FerrerAllergy Department, Clínica Universidad de Navarra, Pamplona, Spain
 show all
Pages 1225-1228 | Published online: 23 Jul 2013

Bibliography

  • Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA2LEN(/EDF/WAO guideline:management of urticaria. Allergy 2009;64:1427-43
  • Sanchez-Borges M, Asero R, Ansotegui IJ, et al. Diagnosis and Treatment of Urticaria and Angioedema: a Worldwide Perspective. World Allergy Organ J 2012;5(11):125-47
  • Spector SL, Tan RA. Effect of omalizumab on patients with chronic urticaria. Ann Allergy Asthma Immunol 2007;99(2):190-3
  • Kaplan AP, Joseph K, Maykut RJ, et al. Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol 2008;122(3):569-73
  • Romano C, Sellitto A, De Fanis U, et al. Maintenance of remission with low-dose omalizumab in long-lasting, refractory chronic urticaria. Ann Allergy Asthma Immunol 2010;104:95-7
  • Maurer M, Altrichter S, Bieber T, et al. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. J Allergy Clin Immunol 2011;128(1):202-9
  • Saini S, Rosen KE, Hsieh H-J, et al. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine–refractory chronic idiopathic urticaria. J Allergy Clin Immunol 2011;128(3):567-73
  • Ferrer M, Gamboa P, Sanz ML, et al. Omalizumab is effective in nonautoimmune urticaria. J Allergy Clin Immunol 2011;127(5):1300-2
  • Buyukozturk S, Gelincik A, Demirturk M, et al. Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: a real life survey. J Dermatol 2012
  • Nam YH, Kim JH, Jin HJ, et al. Effects of omalizumab treatment in patients with refractory chronic urticaria. Allergy Asthma Immunol Res 2012;4(6):357-61
  • Song CH, Stern S, Giruparajah M, et al. Long-term efficacy of fixed-dose omalizumab for patients with severe chronic spontaneous urticaria. Ann Allergy Asthma Immunol 2013;110(2):113-17
  • Maurer M, Rosén K, Hsieh HJ, et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med 2013;368(10):924-35
  • Mlynek A, Zalewska-Janowska A, Martus P, et al. How to assess disease activity in patients with chronic urticaria? Allergy 2008;63(6):777-80

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.